Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs.
about
Canine hemophagocytic histiocytic sarcoma: a proliferative disorder of CD11d+ macrophages.Evaluation of platelet activation in canine immune-mediated haemolytic anaemia.Immunomodulatory drugs and their application to the management of canine immune-mediated disease.Idiopathic immune-mediated thrombocytopenia and recent vaccination in dogs.Portal vein thrombosis in 33 dogs: 1998-2011.Clinical characteristics and prognostic factors in dogs with histiocytic sarcomas in Japan.Evaluation of a DLA-79 allele associated with multiple immune-mediated diseases in dogs.Treatment of 5 dogs with immune-mediated thrombocytopenia using RomiplostimEffect of oral administration of unfractionated heparin (UFH) on coagulation parameters in plasma and levels of urine and fecal heparin in dogsLack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.Comparison of computed tomography pulmonary angiography and point-of-care tests for pulmonary thromboembolism diagnosis in dogsSuspected adverse reactions to vaccination in Canadian dogs and cats.Analysis of DLA-DQB1 and polymorphisms in CTLA4 in Cocker spaniels affected with immune-mediated haemolytic anaemiaProcoagulant microparticles in dogs with immune-mediated hemolytic anemiaThe use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia.The Effects of Cyclosporine and Aspirin on Platelet Function in Normal Dogs.Comparison of 4 direct Coombs' test methods with polyclonal antiglobulins in anemic and nonanemic dogs for in-clinic or laboratory use.Canine idiopathic immune-mediated haemolytic anaemia: a review with recommendations for future research.Systematic review of evidence relating to the treatment of immune-mediated hemolytic anemia in dogs.Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia.Anti-platelet therapy in small animal medicine.Thromboelastographic monitoring of the effect of unfractionated heparin in healthy dogs.Biologic variability and correlation of platelet function testing in healthy dogs.Antiphospholipid antibodies in dogs with immune mediated hemolytic anemia, spontaneous thrombosis, and hyperadrenocorticism.Effect of premedication and other factors on the occurrence of acute transfusion reactions in dogs.Evaluation of the relationship between clinical variables and thromboelastographic findings in dogs with protein-losing nephropathy.Seasonality of immune-mediated hemolytic anemia in dogs from southern California.Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs.Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia.Successful treatment of acute tumor lysis syndrome in a dog with multicentric lymphoma.Neutrophil Extracellular Traps in Plasma from Dogs with Immune-mediated Hemolytic Anemia.In vitro Inhibition of Canine Complement-Mediated Hemolysis.Establishment of reference ranges and evaluation of in vitro concentration-dependent platelet inhibition by acetylsalicylic acid for multiple electrode impedance aggregometry in healthy dogs.Evaluation of prognostic indicators for canine primary immune-mediated haemolytic anaemia and application of a scoring system for the determination of prognosis.Canine Neutrophil Extracellular Traps Enhance Clot Formation and Delay Lysis.The effects of cyclosporine on platelet function and cyclooxygenase expression in normal dogs.The use of therapeutic plasma exchange to reduce serum bilirubin in a dog with kernicterus.Presumptive Ischemic Brain Infarction in a Dog with Evans’ Syndrome
P2860
Q33372609-D1BE30B1-3C60-4EB5-97ED-758FEC3B7D86Q33390603-3AFBAB10-E615-4D0B-BF20-2C8CE982699FQ33393823-377EDB6B-0814-4CC8-989A-352CCCE64C24Q33398628-9398D0F7-910E-41C8-983D-8048829FAE19Q33399920-3FE14646-7D8F-4987-B5B5-050FECD7A3A5Q33412761-9505D6BC-1626-4DB9-A0BB-8D2D9CAC55D1Q33428734-A4DFAD69-A715-4867-8CE2-C00ABD4EC938Q33432920-2BE12049-A982-4A25-95F5-3889FD765636Q33797769-B5B05595-E0C5-496F-A5EF-E19E1D721C9BQ33871622-61C048B0-DDCF-436B-ADEA-A1E33B8AD074Q35770558-44FAF39C-ACD9-46AF-985A-1304341565D4Q36067673-0EF58E39-A1B7-4559-A44F-CDAE78FBA94CQ36084432-096BEF90-CA48-420D-B5BB-5D263B428D62Q36974952-0415712C-EC11-4E84-9E73-30F7DC41367AQ37277075-D27BD0C5-2089-4471-A581-CDB7AEF493CEQ37375461-F6B2692E-5A0C-4281-B3EA-2E897EBF28C2Q37731739-58597A5E-3F36-4943-856E-0D54BC83CD3BQ37949698-D9323D85-776C-4A31-B513-1487CEBF9F70Q38070814-DFCDE552-B85D-4C26-848E-6094532F3793Q38077297-C19CB0C9-33D9-4D6F-8E53-F34E2E1C2A77Q38770733-8B80A57B-60E1-4076-88D0-6BA01242E736Q38812360-6AE736CB-7A16-4E67-9225-8E8F9819A4ABQ38961059-04C431D7-0ABC-4076-BAAF-C9119F20D5F8Q39630876-20F02DA6-A20F-41D6-877A-59AB42AF109FQ40150149-68A0D94C-6D5D-41FD-95E6-944256B7AB33Q40321424-71AC6701-F2AE-4C1D-919A-6863A3D23A4EQ42218489-1E75DD8E-3471-42FE-904D-C3CF128F8997Q43923331-4EB11697-48D6-4D43-BB8D-A02D698099E2Q46175382-FA449CD3-A7EA-4BF3-8001-0DB9B1E83622Q46807319-7878206C-2220-4DE7-94CC-BB263A5B85E9Q48162373-A78B1497-F132-4169-BCE3-8FF1D6E5E0ACQ48242958-A87439CB-C825-45AC-8854-C412F85426A8Q48306826-8FDF47D8-290B-4909-A470-B06FA9B6A897Q50574707-AD174EE6-AFB4-4393-AB5C-0EA3A91429A4Q51084109-26075F78-03A4-4153-8ED6-2765AE63AE38Q51300207-3B2E4CF5-5773-4DB8-83EB-CF5BC1175397Q53228288-1DFEA860-E7F3-4B66-B161-B54832FCB1CDQ59039731-8FFB7B8A-2F2D-46CB-97C8-BD775CC4A8AC
P2860
Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prognostic factors for mortali ...... etrospective study of 72 dogs.
@ast
Prognostic factors for mortali ...... etrospective study of 72 dogs.
@en
type
label
Prognostic factors for mortali ...... etrospective study of 72 dogs.
@ast
Prognostic factors for mortali ...... etrospective study of 72 dogs.
@en
prefLabel
Prognostic factors for mortali ...... etrospective study of 72 dogs.
@ast
Prognostic factors for mortali ...... etrospective study of 72 dogs.
@en
P2093
P1476
Prognostic factors for mortali ...... etrospective study of 72 dogs.
@en
P2093
Anthony P Carr
David L Panciera
Linda Kidd
P304
P356
10.1111/J.1939-1676.2002.TB02378.X
P577
2002-09-01T00:00:00Z